Skip to main content
. 2024 Sep 12;54(12):2350870. doi: 10.1002/eji.202350870

Figure 2.

Figure 2

Personalized medicine approaches to develop tailored GPCR anticancer treatment. The figure represents a proposed personalized medicine pipeline to perform patient‐specific GPCR cancer treatments. Tumor biopsies are analyzed with cutting‐edge techniques such as scRNA‐seq, spectral flow cytometry, and spatial transcriptomics. Data are then integrated and analyzed using dedicated bioinformatic pipelines to compile a protumorigenic GPCR list to be targeted in each specific patient.